Brief: Dyadic And Medytox To Develop Vaccines Against Covid-19 Variants

Dyadic International

23/03/2021 13:35

March 23 (Reuters) - Dyadic International Inc  DYAI.O :
    * DYADIC AND MEDYTOX TO DEVELOP VACCINES AGAINST COVID-19
VARIANTS
    * DYADIC INTERNATIONAL INC - EXPANDING EXISTING COVID-19
VACCINE
RESEARCH COLLABORATION WHICH BEGAN IN JULY 2020
    * DYADIC - MEDYTOX, CO TO CO-DEVELOP C1 ENABLED COVID-19
VACCINES
& BOOSTERS WHICH WILL IMMUNIZE PEOPLE AGAINST 2/MORE OF CURRENT,
FUTURE COVID-19 VARIANTS
    * DYADIC INTERNATIONAL INC - MANUFACTURING PROTOCOLS TO
PRODUCE
VACCINES FROM C1 HAVE BEEN SUCCESSFULLY TRANSFERRED AND
REPRODUCED AT MEDYTOX

Source text for Eikon:  ID:nGNE2NRXcd 
Further company coverage:  DYAI.O 

 ((Reuters.Briefs@thomsonreuters.com;))